Market

How Will BioHub Maryland Impact Biopharma Job Growth and Training?
Management & Regulatory How Will BioHub Maryland Impact Biopharma Job Growth and Training?

The establishment of the BioHub Maryland Training and Education Center in Montgomery County marks a pivotal moment for the biopharma industry, both locally and nationally. With a $3 million investment from Montgomery County coupled with an additional $1.25 million from the Moore-Miller

How Will the Jubilant-SIS Partnership Transform Nuclear Medicine?
Management & Regulatory How Will the Jubilant-SIS Partnership Transform Nuclear Medicine?

Jubilant Radiopharma and Simplified Imaging Solutions (SIS) have announced a strategic partnership aimed at enhancing nuclear medicine services for healthcare providers across the United States. This collaboration is set to create a comprehensive, full-service solution designed to simplify nuclear

Roche Ends UCB Partnership on Anti-Tau Alzheimer's Drug Bepranemab
Management & Regulatory Roche Ends UCB Partnership on Anti-Tau Alzheimer's Drug Bepranemab

Roche's recent decision to return the rights to UCB’s anti-tau antibody bepranemab comes after a four-year investment in the Alzheimer's disease drug candidate, which was initially valued at up to $2 billion in milestones. This strategic move happens just before the release of phase 2a data for the

Pharma M&A Trends: High-Value Focus and Innovation Amid Market Fluctuations
Management & Regulatory Pharma M&A Trends: High-Value Focus and Innovation Amid Market Fluctuations

In recent years, the pharmaceutical and biotechnology sectors have experienced a dynamic landscape in mergers and acquisitions (M&A). From major multimillion-dollar deals to strategic acquisitions targeting high-demand therapeutic areas, the industry has witnessed fluctuations driven by various

Quantum BioPharma Expands with Unbuzzd Launch in Global Markets
Management & Regulatory Quantum BioPharma Expands with Unbuzzd Launch in Global Markets

Quantum BioPharma Ltd. (NASDAQ: QNTM) is making strategic moves to enhance its presence in the health and wellness sector through its subsidiary, Celly Nutrition Corp. Celly Nutrition has clinched a Master Distribution Agreement with FUSION Consulting Group for its innovative product, Unbuzzd.

Is Xeris Biopharma Holdings Inc a Promising Investment Opportunity?
Management & Regulatory Is Xeris Biopharma Holdings Inc a Promising Investment Opportunity?

The biotech industry is bustling with innovation and potential, and Xeris Biopharma Holdings Inc (NASDAQ: XERS) is making waves. This article aims to delve deep into the nuts and bolts of Xeris Biopharma’s recent market activities, financial health, insider trading, analysts' ratings, valuation

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later